Language

News topic

Expected end: Ende Oktober 2026

All current shortage notices related to Expected end: Ende Oktober 2026, structured by product, country, active ingredient and reporting period.

8 notices

← All shortages

Denmark

Salazopyrin Entabs 500 mg enterotabletter

Active ingredient: nicht angegeben

View notice details →
Denmark

Sendoxan 50 mg overtrukne tabletter

Active ingredient: nicht angegeben

View notice details →
Denmark

Cystadrops 3,8 mg/ml øjendråber, opløsning

Active ingredient: Mercaptamin (Mercaptaminhydrochlorid)

View notice details →
Denmark

Oxylan Depot 20 mg depottabletter (30 stk.)

Active ingredient: Oxycodon

View notice details →
Denmark

Ogivri 420 mg pulver til koncentrat til infusionsvæske, opløsning

Active ingredient: Trastuzumab

View notice details →
Denmark

Lacosamide Stada 100 mg filmovertrukne tabletter

Active ingredient: Lacosamid

View notice details →
Denmark

Sylvant 100 mg pulver til koncentrat til infusionsvæske, opløsning

Active ingredient: Siltuximab

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.